middl
east
respiratori
syndrom
coronaviru
merscov
identifi
saudi
arabia
januari
laboratoryconfirm
merscov
case
report
http
wwwwhointemergenciesmerscoven
multipl
studi
suggest
dromedari
camel
sourc
human
merscov
infect
merscovspecif
antibodi
detect
serum
dromedari
camel
across
northern
africa
across
arabian
peninsula
israel
geograph
locat
place
israel
risk
merscov
infect
date
merscovrel
ill
report
burden
merscov
infect
isra
popul
unknown
seropreval
merscovspecif
antibodi
isra
dromedari
camel
unknown
object
studi
determin
preval
merscov
seroposit
dromedari
camel
israel
preval
merscov
antibodi
isra
camel
examin
camel
sera
collect
four
farm
across
israel
merscovspecif
microneutr
mnt
assay
confirm
merscovspecif
immunofluoresc
assay
ifa
although
studi
rule
potenti
antibodi
crossreact
ifa
presenc
bovin
coronavirusspecif
antibodi
appear
impact
detect
merscov
antibodi
mnt
merscov
neutral
antibodi
detect
camel
sera
associ
observ
presenc
neutral
antibodi
camel
age
gender
find
extend
known
rang
merscov
circul
middl
eastern
camel
high
rate
merscovspecif
antibodi
seroposit
dromedari
camel
absenc
report
human
mer
case
suggest
still
much
learn
dynam
cameltohuman
transmiss
merscov
coronaviru
dromedari
camel
merscov
middl
east
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
merscov
member
betacoronaviru
genu
lineag
c
first
identifi
saudi
arabia
januari
laboratoryconfirm
human
merscov
case
report
includ
least
merscovrel
death
multipl
studi
suggest
dromedari
camel
major
sourc
human
merscov
infect
merscovspecif
antibodi
detect
serum
dromedari
camel
across
northern
africa
includ
tunisia
egypt
sudan
ethiopia
nigeria
kenya
somalia
across
arabian
peninsula
includ
jordan
saudi
arabia
qatar
oman
unit
arab
emir
hemida
et
al
meyer
et
al
muller
et
al
merscov
neutral
antibodi
detect
archiv
camel
serum
sampl
suggest
longterm
circul
merscov
dromedari
region
merscov
genom
detect
isol
sequenc
camel
respiratori
specimen
northern
africa
nigeria
saudi
arabia
air
sampl
camel
barn
own
known
merscovinfect
human
alagaili
et
al
azhar
et
al
chu
et
al
haagman
et
al
genom
epidemiolog
studi
compar
merscov
sequenc
household
cluster
camel
dromedari
farm
human
contact
uae
muhairi
et
al
paden
et
al
patient
correspond
merscovposit
camel
saudi
arabia
kasem
et
al
demonstr
camel
potenti
sourc
human
merscov
infect
israel
geograph
locat
middl
east
border
jordan
human
case
report
merscovspecif
antibodi
detect
serum
dromedari
camel
suggest
isra
citizen
may
risk
merscov
infect
howev
date
merscovrel
ill
report
israel
seropreval
merscovspecif
antibodi
isra
dromedari
camel
unknown
object
studi
determin
preval
merscov
seroposit
isra
camel
serum
specimen
dromedari
camel
across
four
differ
locat
israel
site
ad
tabl
collect
may
june
previous
describ
rasi
rudol
schwartz
giladi
farm
n
locat
east
jerusalem
farm
bd
n
respect
locat
negev
desert
southern
israel
origin
camel
prior
associ
four
locat
unknown
camel
use
tourism
industri
studi
includ
male
n
femal
n
camel
age
year
old
blood
sampl
taken
jugular
vein
punctur
serum
sampl
obtain
day
collect
unclot
blood
use
serum
separ
tube
serum
specimen
ship
cdc
inactiv
gamma
irradi
rad
cobalt
irradi
inactiv
potenti
pathogen
store
use
studi
approv
tel
aviv
souraski
medic
center
institut
anim
care
use
committe
studi
merscovspecif
neutral
mnt
assay
perform
determin
presenc
neutral
antibodi
camel
sera
use
jordan
strain
merscov
follow
previous
establish
method
sui
et
al
initi
mnt
assay
perform
use
titrat
rang
sampl
mnt
titr
titrat
mnt
perform
use
polyclon
guinea
pig
antibovin
coronaviru
mebu
strain
nih
biodenfens
emerg
infect
research
resourc
repositori
antiserum
evalu
antibodi
crossneutr
initi
ifa
screen
perform
use
sera
dilut
follow
modifi
previous
publish
protocol
corman
et
al
briefli
merscov
jordan
infect
vero
cell
slide
fix
permeabil
block
whole
camel
serum
abcam
incub
serum
stain
fitcconjug
llama
antigoat
igg
h
l
bethyl
lab
figur
whole
camel
block
serum
screen
absenc
specimen
verifi
block
result
fals
posit
signal
specimen
indetermin
presenc
merscov
antibodi
rescreen
final
indetermin
determin
made
two
independ
screen
ifa
indetermin
ifa
titr
determin
repeat
screen
serial
dilut
camel
sera
statist
analys
perform
use
fisher
exact
test
pvalu
consid
signific
fiftyon
camel
sera
merscov
neutral
antibodi
titr
tabl
thirtyf
serum
sampl
high
merscov
neutral
antibodi
titr
rang
tabl
ifa
titr
rang
greater
tabl
merscov
neutral
titr
increas
n
merscovspecif
titr
determin
ifa
also
increas
sixteen
camel
lower
merscov
serum
neutral
antibodi
titr
rang
tabl
camel
ifa
titr
equal
three
camel
tabl
data
shown
attempt
detect
coronaviru
genom
materi
rtpcr
camel
sera
unsuccess
inabl
detect
genom
materi
may
part
due
three
key
factor
studi
one
specimen
collect
optim
nucleic
acid
preserv
two
prior
studi
sera
irradi
rad
upon
arriv
cdc
per
import
requir
note
nd
done
vitro
microneutr
assay
perform
use
jordan
strain
merscov
begin
serial
dilut
rang
microneutr
titr
report
dilut
factor
least
one
three
independ
well
complet
inhibit
viru
infect
b
immunofluoresc
assay
ifa
perform
jordan
strain
merscov
begin
dilut
final
dilut
c
sera
evalu
ifa
presenc
bovin
coronaviru
antibodi
bcov
dilut
sampl
consid
indetermin
inconclus
result
obtain
two
independ
evalu
dilut
abil
specif
detect
merscovspecif
antibodi
howev
antibodi
specif
merscov
neutral
bcov
sarscov
infect
bcovspecif
antibodi
neutral
merscov
infect
hemida
et
al
perera
et
al
consist
find
antiserum
bcov
crossneutr
merscov
mnt
use
studi
confirm
specif
assay
discrimin
two
virus
data
shown
associ
merscov
neutral
antibodi
gender
age
camel
locat
number
merscov
neutral
antibodi
posit
camel
significantli
higher
site
c
p
respect
compar
site
b
significantli
higher
site
c
p
significantli
higher
site
p
specimen
test
bcov
indetermin
specimen
n
origin
site
posit
antibodi
merscov
